Reliable and precise lipoprotein detection based on a self-priming hairpin-triggered Cas12a/crRNA based signaling

Xiaoya Liu1, Hai Peng2,3, Lisha Gong2,4

  • 1Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

The Analyst
|November 27, 2024
PubMed

Insights

A new method accurately measures intact high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, crucial for assessing cardiovascular disease risk. This technique offers precise quantification for improved clinical health management.

Area of Science:

  • Biochemistry
  • Molecular Diagnostics
  • Cardiovascular Research

Background:

  • Cardiovascular disease is a leading cause of mortality, strongly associated with dyslipidemia.
  • Dyslipidemia involves abnormal levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL).
  • Current methods for measuring HDL and LDL often quantify cholesterol content, not intact particle numbers, potentially misrepresenting cardiovascular risk.

Purpose of the Study:

  • To develop a novel, precise, and sensitive method for quantifying intact high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles.
  • To overcome limitations of conventional methods that measure cholesterol content instead of particle number.
  • To provide a tool for accurate assessment of cardiovascular disease risk.

Main Methods:

  • Utilized an antibody-based immobilization technique.
  • Employed a self-priming hairpin-triggered Cas12a/crRNA signaling strategy.
  • Developed a method for direct and sensitive detection of intact HDL and LDL particles without sample isolation.

Main Results:

  • Achieved detection limits of 12.3 mg dL-1 for HDL and 5.4 mg dL-1 for LDL.
  • Demonstrated accurate and sensitive quantification of intact HDL and LDL particles.
  • Validated the method's suitability for analyzing lipoproteins in clinical samples.

Conclusions:

  • The developed technique enables precise measurement of actual HDL and LDL particle concentrations.
  • This platform offers significant potential for clinical applications in diagnosing and managing dyslipidemia and cardiovascular disease.
  • Provides a more accurate assessment of cardiovascular risk by measuring intact lipoprotein particles.

Related Concept Videos